Insider · CIK 0001339811
Lee C Wortham
Files at EVBN (EVANS BANCORP INC). First filing Nov 14, 2023, latest Nov 14, 2023.
In brief
Lee C Wortham files SEC Form 4 as director at EVBN (EVANS BANCORP INC). Since Nov 14, 2023, Lee C Wortham has reported 1 open-market buy worth $109k and 0 open-market sells worth $0, the latest filed on Nov 14, 2023.
A track record needs three past buys with six months of prices behind them; Lee C Wortham has 0, so none is measured yet.
The newest scored trade: bought $109k of EVBN on Nov 10, 2023, filed Nov 14, 2023, scored 39 (weak).
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 2, 2025 | EVBN EVANS BANCORP INC | DDisposition to issuer Common Stock | -20,538 | - | - | 0 | May 2, 2025 |
| Nov 10, 2023 | EVBN EVANS BANCORP INC | POpen-market purchase Common Stock | +1,034 | $26.91 | $28k | 16,893 | Nov 14, 2023 |
| Nov 13, 2023 | EVBN EVANS BANCORP INC | POpen-market purchase Common Stock | +2,966 | $27.23 | $81k | 19,859 | Nov 14, 2023 |
Questions about Lee C Wortham
Answered from the filings on this page, as of the latest one.
Is Lee C Wortham buying or selling?
Not in the last 12 months. Lee C Wortham's latest open-market trade on SEC Form 4 was bought $109k of EVBN on Nov 10, 2023.
How did Lee C Wortham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lee C Wortham has 0.
Where does Lee C Wortham file Form 4?
Lee C Wortham has filed Form 4 at EVBN (EVANS BANCORP INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.